Stay updated on BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial
Sign up to get notified when there's something new on the BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial page.

Latest updates to the BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial page
- Check6 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the study details and indicating access is blocked. The error screen presents a minimal layout with navigation to the Home page and a basic site footer.SummaryDifference21%

- Check54 days agoChange DetectedThe revision tag on the page has been updated from v3.6.5 to v3.6.6, signaling a system or template version update.SummaryDifference0.1%

- Check61 days agoChange DetectedA new identifier 2017 ( U.S. NIH Grant/Contract ) was added to the list of Other Study ID Numbers in the study record, indicating NIH-related funding designation.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page now displays Revision: v3.6.5, and the Investigator Inquiry Form and the text Revision: v3.6.4 were removed.SummaryDifference0.1%

Stay in the know with updates to BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial page.